GOLGA3 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population targeting the GOLGA3 gene. This loss-of-function model is established in the HAP1 near-haploid human cell line, offering a genetically defined system for investigating Golgin-mediated cellular processes. The polyclonal nature of the knockout pool captures a representative range of gene disruptions, enabling robust phenotypic analysis without clonal selection bias. By eliminating GOLGA3 function, this model serves as a versatile tool for dissecting Golgi ribbon integrity and membrane trafficking pathways.
The HAP1 cell line is a near-haploid chronic myelogenous leukemia (CML) cell line with characteristics of hematopoietic progenitor cells. Its near-haploid karyotype reduces genetic complexity, facilitating unambiguous interpretation of knockout phenotypes and minimizing compensatory effects from homologous genes. Derived from a CML background, HAP1 cells retain critical features of hematopoietic signaling and proliferation, making them particularly relevant for disease models involving immune cell function and autoimmune pathology.
GOLGA3 encodes a member of the golgin family of coiled-coil proteins that localizes to the Golgi apparatus and functions in vesicle tethering and Golgi ribbon maintenance. Mechanistically, GOLGA3 interacts with key trafficking regulators including RAB6A, GORASP1, USO1, and ARF1 to coordinate membrane flow. GOLGA3 activity is regulated by mitotic kinases such as PLK1 and CDK1, and its disruption impairs Golgi organization, leading to fragmentation and defective secretory pathway flux. Downstream consequences include altered glycosylation and aberrant cell surface receptor expression, affecting immune recognition and signaling. The broader pathway involves GORASP1, GM130, COPI vesicles, and RAB6A-mediated transport steps.
In the HAP1 context, GOLGA3 knockout generates a simplified cellular model for studying Golgi structure-function dynamics. The hematopoietic origin is of particular importance for autoimmune disease research, as abnormal protein trafficking and autoantigen presentation are implicated in conditions such as systemic lupus erythematosus and Sj?gren’s syndrome. The near-haploid background enhances the penetrance of the knockout, providing a sensitive readout for phenotypic changes in Golgi organization, protein secretion, and surface receptor display.
These polyclonal knockout cells are well-suited for a range of experimental applications, including immunofluorescence staining of Golgi markers (e.g., GM130, TGN46), temperature-sensitive VSV-G ts045 trafficking assays, and western blotting for glycoprotein maturation. They can be employed in secretion assays to measure constitutive and regulated exocytosis, and in high-throughput screening for modulators of Golgi function. Additionally, this model supports investigations into autoimmune mechanisms by evaluating how altered protein trafficking influences immune cell interactions. For further information, please contact Ascent Research.
